Genprex (GNPX) Stock Price, Quote, News & History | Benzinga

Genprex Inc (GNPX) Stock Price, Quote, News & History

GNPXNASDAQ

Trade with Public

Trade with Public

$3.95

-0.04-1%

At close: Aug 20, 5:00 PM EST

$3.94

-0.01-0.25%

After Hours: 4:37 PM EST

Earnings: Q2 2026 Earnings were released on Fri Aug 14th, after the market close

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$3.99

Close

$3.95

Volume / Avg.

70.33K / 160.52K

Day Range

$3.88 - $4.05

52 Wk Range

3.83 - 1.21K

Market Cap

$1.99M

P/E Ratio

0.12

Dividend Yield

-

Exchange

NASDAQ

RSI

28

Short Interest

7.32%

Days to Cover

1

Recent Genprex Inc News

Top 3 Health Care Stocks That Are Set To Fly In Q2

The health care sector has oversold stocks with RSI below 30, presenting an opportunity for traders to buy undervalued companies.

Avi Kapoor

Top Ranking Stock Picker From Congress Is Back Buying Small Cap Stocks Again: Here Are The Tickers

A Congress member continues to buy small cap stocks. Here's the latest names added to his investment portfolio in March 2026.

Chris Katje

Congressman Who Bought Small-Cap Stocks In 2025 Is Back With New 2026 Pick: Here's What He's Buying

A member of Congress is buying stock in two small cap companies in 2026. Here's the stocks and why investors should be watching.

Chris Katje

Congressman Who Was Top 2025 Stock Picker Buys Shares Of $5M Company You've Never Heard Of

A Republican U.S. Representative made multiple trades in 2025, including Cracker Barrel and a little-known gene therapy firm.

Chris Katje

Move Over, Pelosi: This Congress Member Posted 2025's Best Market Return With A 52% Gain

The list of the top 10 members of Congress for 2025 investment portfolio gains. Where did Marjorie Taylor Greene rank and how close was Nancy Pelosi to the Top 10?

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-15.56M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

29.37M

Free Cash Flow (TTM)

-15.56M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

13.81M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$13.14M

PE Ratio (TTM)

0.12

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.14

Earnings Yield % (TTM)

865.08%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$29.30

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$15.15M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$3.99

Close

$3.95

Volume / Avg.

70.33K / 160.52K

Day Range

$3.88 - $4.05

52 Wk Range

3.83 - 1.21K

Market Cap

$1.99M

P/E Ratio

0.12

Dividend Yield

-

Exchange

NASDAQ

RSI

28

Short Interest

7.32%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient po...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Genprex (GNPX) stock?

A

You can purchase shares of Genprex (NASDAQ:GNPX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Genprex (GNPX) competitors?

A

Other companies in Genprex’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Genprex (GNPX) stock?

A

Genprex has a consensus price target of $10.00.

Q

What is the current price for Genprex (GNPX)?

A

The stock price for Genprex (NASDAQ: GNPX) is $3.94 last updated August 20, 2026 at 4:37 PM EDT.

Q

Does Genprex (GNPX) pay a dividend?

A

There are no upcoming dividends for Genprex.

Q

When is Genprex (NASDAQ:GNPX) reporting earnings?

A

Genprex does not have any upcoming earnings scheduled.

Q

Is Genprex (GNPX) going to split?

A

There is no upcoming split for Genprex.

Q

What sector and industry does Genprex (GNPX) operate in?

A

Genprex is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.